CHICAGO, IL — A new "smart pill" called Gelesis100 safely leads to greater weight loss in overweight and obese individuals compared with those who receive an active comparator/placebo capsule, while ...

BOSTON--(BUSINESS WIRE)--Gelesis, a biotechnology company developing first-in-class mechanotherapeutics to treat obesity and other chronic diseases related to the gastrointestinal (GI) pathway, today ...

6 out of 10 of adults with overweight or obesity had a clinically meaningful response to Gelesis100, losing on average 10% of their weight (22 pounds) and nearly 4 inches from their waists. Adults ...

Please provide your email address to receive an email when new articles are posted on . “There is ... an urgent need for therapies that increase patients’ odds for achieving clinically meaningful ...

A new 'smart pill' called Gelesis100 leads to greater weight loss in overweight and obese individuals compared with those who receive an active comparator/placebo capsule, while all subjects have ...

BOSTON--(BUSINESS WIRE)--Gelesis, a biotechnology company developing first-in-class therapies to treat chronic diseases related to the gastrointestinal (GI) pathway, today announced topline results ...

Gelesis has claimed success in a pivotal trial of its obesity candidate. More than half of participants who took the swelling hydrogel particles lost weight, encouraging Gelesis to file for approval ...

A slimming pill that forms a gel in the stomach doubles the chance of successful dieting, research has shown. The Gelesis100 capsule works by releasing tiny particles in the stomach which absorb 100 ...

A young Boston company thinks it has what could be a safe, effective and noninvasive way to help overweight and obese people drop those dangerous extra pounds. Investors including PureTech Ventures ...

Gelesis100 is a non-systemic, superabsorbent hydrogel in development for the potential treatment of overweight or obesity. It is made by cross linking two naturally-derived building blocks, modified ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Among the top endocrinology stories last ...